VEGF attenuates development from cardiac hypertrophy to heart failure after aortic stenosis through mitochondrial mediated apoptosis and cardiomyocyte proliferation
2011

VEGF Helps Heart Function After Aortic Stenosis

Sample size: 50 publication 10 minutes Evidence: moderate

Author Information

Author(s): Xu Xiao H, Xu Jing, Xue Lei, Cao Hai L, Liu Xiang, Chen Yi J

Primary Institution: The First Affiliated Hospital of Nanjing Medical University

Hypothesis

Pre-operative treatment with VEGF improves AS-induced cardiac dysfunction to better prepare patients for aortic valve replacement.

Conclusion

VEGF can repair the transition from compensatory cardiac hypertrophy to heart failure caused by aortic stenosis.

Supporting Evidence

  • VEGF treatment increased capillary density in the heart.
  • VEGF reduced cardiomyocyte apoptosis.
  • VEGF promoted cardiomyocyte proliferation.
  • VEGF preserved cardiac function in mice with aortic stenosis.

Takeaway

This study shows that a special protein called VEGF can help the heart work better after a serious heart problem called aortic stenosis.

Methodology

Adult male mice were subjected to aortic stenosis or sham operation, followed by treatment with adenoviral VEGF or control, and assessed for cardiac function and structure.

Limitations

The study was conducted in a mouse model, which may not fully replicate human conditions.

Participant Demographics

Adult male C57BL/6 mice

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1749-8090-6-54

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication